Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2066)	1/2/2008 1:10:58 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

MLNM was up 10.14% & is still up > 8%. It will receive some $40M from JNJ as Velcade sales reached its overseas goal & Dr. Deborah Dunsire, its CEO, is scheduled to discuss MLNM's accomplishments,goals and financial guidance for 2008 next Wednesday in Frisco. bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2066)	2/11/2008 12:52:52 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

IVD continues to trade at low volume, but it has been forming a base at the $0.50 level & the last 2 days in which trading volume was > 100Ks were on Sep 26 & Dec 28 both "up-days" <g> bigcharts.marketwatch.com Since IVX controls the majority of the stock, IVD's float is only around 6.9M The stock is trading around 0.6xBV The short ratio remains low around 0.3x its ADV.<g> bigcharts.marketwatch.com The "analysts" don't have a target for IVD, but I will keep mine around $1 <g> bigcharts.marketwatch.com Bernard